Fetal Pulse Oximetry Trial (FOX)

Sponsor
The George Washington University Biostatistics Center (Other)
Overall Status
Terminated
CT.gov ID
NCT00098709
Collaborator
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (NIH)
10,000
13
33.1
769.2
23.3

Study Details

Study Description

Brief Summary

The purpose of this study is to determine if the information provided to the physician by a fetal pulse oximeter during labor will reduce the chances of a cesarean delivery.

Condition or Disease Intervention/Treatment Phase
  • Device: Fetal pulse oximeter
Phase 3

Detailed Description

Information on fetal well-being during labor is of great importance to the managing physician. The current use of the fetal heart rate monitor provides some information on fetal condition, and is the primary tool used to determine if immediate operative delivery is required. The fetal pulse oximeter can provide additional information regarding fetal oxygen saturation.

Intervention: A fetal oxygen saturation sensor is placed in the uterus, between the fetal cheek or forehead and the uterine wall. In half of the patients, the managing physician will have access to fetal oxygen saturation and fetal heart rate monitoring. In the other half of the patients, labor will be monitored by fetal heart rate alone.

Study hypothesis: The additional information provided by the use of the fetal pulse oximeter will reduce the chances of a cesarean delivery. The primary outcome is cesarean section for any indication and secondary outcomes are cesarean delivery for non-reassuring fetal heart rate or dystocia, and neonatal morbidity.

Study Design

Study Type:
Interventional
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
A Randomized Clinical Trial of Fetal Pulse Oximetry
Study Start Date :
May 1, 2002
Study Completion Date :
Feb 1, 2005

Outcome Measures

Primary Outcome Measures

  1. cesarean delivery (any indication) []

Secondary Outcome Measures

  1. cesarean delivery for non-reassuring fetal heart rate []

  2. cesarean delivery for dystocia []

  3. neonatal morbidity []

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion criteria:
  • Nulliparous

  • Singleton, cephalic pregnancy

  • Gestational age at least 36 weeks, 0 days

  • Cervical dilatation >= 2 cm

  • Station -2 or below (5ths scale)

  • Ruptured membranes

  • Internal monitoring devices placed

Exclusion criteria:
  • Need for immediate delivery

  • Planned cesarean delivery

  • Cervical dilatation > 6 cm

  • Known fetal anomaly or demise

  • Multifetal gestation

  • Maternal fever

  • Placenta previa

  • Previous uterine surgery

  • Active HSV infection

  • Known HIV or hepatitis infection

  • Diabetes requiring insulin

  • Heart disease requiring medication

  • Known chronic renal disease

  • Enrollment in another labor study

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Alabama - Birmingham Birmingham Alabama United States 35233
2 Northwestern University Chicago Illinois United States 60611
3 Wayne State University Detroit Michigan United States 48201
4 Columbia University New York New York United States 10032
5 University of North Carolina - Chapel Hill Chapel Hill North Carolina United States 27599
6 Wake Forest University School of Medicine Winston-Salem North Carolina United States 27157
7 Case Western University Cleveland Ohio United States 44109
8 Dexel University Philadelphia Pennsylvania United States 19107
9 University of Pittsburgh Magee Womens Hospital Pittsburgh Pennsylvania United States 15213
10 Brown University Providence Rhode Island United States 02905
11 University of Texas - Southwest Dallas Texas United States 75235
12 University of Texas - Houston Houston Texas United States 77030
13 University of Utah Medical Center Salt Lake City Utah United States 84132

Sponsors and Collaborators

  • The George Washington University Biostatistics Center
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Investigators

  • Study Director: Cathy Spong, MD, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
  • Principal Investigator: Elizabeth A Thom, Ph.D., George Washington University Biostatistics Center
  • Study Chair: Steven L Bloom, M.D., University of Texas

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

Responsible Party:
The George Washington University Biostatistics Center
ClinicalTrials.gov Identifier:
NCT00098709
Other Study ID Numbers:
  • HD36801-FOX
  • U10HD021410
  • U10HD027869
  • U10HD027917
  • U10HD027860
  • U10HD034116
  • U10HD034208
  • U10HD034136
  • U10HD040500
  • U10HD040485
  • U10HD040544
  • U10HD040545
  • U10HD040560
  • U10HD040512
  • U10HD036801
First Posted:
Dec 8, 2004
Last Update Posted:
Mar 18, 2022
Last Verified:
Mar 1, 2022
Keywords provided by The George Washington University Biostatistics Center

Study Results

No Results Posted as of Mar 18, 2022